| HOME >> MEDICINE >> TECHNOLOGY |
Covidien Offers Imaging Solutions to MedAssets Supply Chain
Systems 80
Siemens, M.D. Anderson Cancer Center Set up Research Centre 80
Bayer, Berlex Merge Operations 80
AION Diagnostics Forays Pre-Clinical Imaging Agent Market 80
ART Acquires Alerion Biomedical 80
EPIX to Merge with Predix 81
Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories 81
Bracco Diagnostics Inks Agreement with Amerinet 81
Vasovist receives Green Signal in Australia 81
AION Diagnostics Develops BioSilicon TM 81
Sonazoid Receives Import Approval 81
Schering AG Divests Radiopharmaceutical Business to Ion Beam
Applications and Institut National des Radioelements 82
Vasovist Receives European Approval 82
Albany Molecular Research Renews Supply Agreement with GE
Healthcare 82
QuantRx Biomedical Corp. Acquires Stake in FluoroPharma 82
Palatin Technologies Withdraws NeutroSpec Imaging Agent 82
Diosynth Bags Contract to Produce Imaging Agent 83
GE Healthcare Signs Marketing Agreement with PhotoCure 83
DRAXIMAGE Receives the Green Signal in Europe 83
Daiichi and Sankyo Sign a Merger Deal 83
12. PRODUCT INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER 84
Insight Agents to Launch Generic Contrast Media Solutions In
Europe 84
Researchers Develop First Biocompatible MRI Contrast Agent 84
Signalomics and Invitrogen Collaborate to Develop Nanocrystal
Reagents 84
Schering AG Collaborates with Stanford University to Develop
Molecular Imaging Agent 84
Schering and Avid to Develop Diagnostic Imaging Agents 84
US National Institutes of Health Develops two PET Imaging Agents 85
13. FOCUS ON SELECT PLAYERS 86
AMAG Pharmaceuticals, Inc. (USA) 86
Bayer Schering Pharma AG (Germany) 86
Bracco Group (Italy) 86
Covidie
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |